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Our previous animal studies showed that maternal Porphyromonas gingivalis infection in a subcutaneous
chamber is associated with hepatic and uterine translocation, as well as systemic induction of maternal
inflammatory responses, both of which were associated with fetal growth restriction (FGR). However, P.
gingivalis-challenged dams had fetuses with either FGR (2 standard deviations below mean weight of nonchal-
lenged dams) or normal weight. Therefore, the objective of this study was to determine whether maternal
infection with P. gingivalis compromises normal fetal development via direct placental invasion and induction
of fetus-specific placental immune responses characterized by a proinflammatory Th1-type cytokine profile. P.
gingivalis-specific DNA was detected in placentas and fetuses of FGR and normal littermates from P. gingivalis-
infected dams. Th1- and Th2-type cytokine mRNA as well as tumor necrosis factor alpha and transforming
growth factor 2 mRNA were examined in placental tissue by using reverse transcription-PCR to determine
Th1/Th2 ratios. For eight litters containing both normal-weight and FGR fetuses, P. gingivalis DNA was
detected only in the placentas of FGR fetuses. All fetuses and all amniotic fluid samples from infected and
control dams were negative for P. gingivalis DNA. mRNA levels of gamma interferon and interleukin-2 (IL-2)
were significantly increased in placentas of FGR fetuses, while expression of IL-10 was significantly decreased
in the same group. These data indicate that, in P. gingivalis-challenged dams, within each litter there is
placenta-specific translocation of P. gingivalis that results in growth restriction of the targeted fetus, which is
associated with a shift in the placental Th1/Th2 cytokine balance.
Periodontitis is a chronic infectious disease, and the primary
etiological agents are gram-negative, anaerobic bacteria that
occupy the tooth-associated biofilm in the subgingival plaque.
Among them, Porphyromonas gingivalis is thought to be a ma-
jor periodontal pathogen (1, 2). Human studies in patients with
periodontitis and animal studies have suggested P. gingivalis
may be an important component in the underlying association
in linking periodontitis to preterm birth (6). Patients with peri-
odontal diseases show that P. gingivalis-specific sensitized T
cells are present in the peripheral blood, indicating systemic
exposure to P. gingivalis (7, 22). Our previous animal studies
showed that maternal P. gingivalis infection in a subcutaneous
chamber is associated with hepatic and uterine translocation,
and this dissemination is correlated with fetuses that exhibit
fetal growth restriction (FGR) (15).
A successful pregnancy is thought to be characterized by a
dominant Th2-type immunity with predominance of interleu-
kin-4 (IL-4) and IL-10 expression over tumor necrosis factor
alpha (TNF-), gamma interferon (IFN-), and IL-2 in the
placenta (28). Th2-type cytokines are associated with humoral
immunity, which is known to favor implantation, induce and
maintain allograft tolerance, and control harmful maternal
responses (13). Th1-type cytokines induce several cytotoxic
and inflammatory reactions which are known to be potentially
deleterious for the conceptus by modulating the integrity of the
placental membrane and uterine tone (20, 21, 29, 30, 32). For
example, TNF- is believed to induce macrophage matrix met-
alloproteinases to weaken the placental membrane and release
prostaglandin E2, which induces uterine constriction (4, 33).
The administration of TNF- and IFN- to pregnant mice
increases fetal abortion and fetal abnormalities such as reduc-
tion of fetal weight and retardation of eye development (34).
Thus, infectious challenges that trigger abnormal pregnancies
may be mediated by changes in the placental Th1/Th2 balance.
In addition, transforming growth factor 2 (TGF-2) is a po-
tent immunosuppressive factor and can help to reduce activa-
tion of NK cells by potentially abortive events, such as intra-
uterine exposure to lipopolysaccharide or to interferons. It has
been reported that TGF-2 production is defective in women
with repeated miscarriages (14).
Our previous studies (17, 24–26) and recent work in a mu-
rine model (15) showed that P. gingivalis infection can result in
hepatic and uterine dissemination, triggering growth restric-
tion of selected fetuses. Since not all fetuses within litters were
affected, we hypothesized that translocation of P. gingivalis or
its components into the placenta may induce local immune
responses that impair placental function, thereby mediating
FGR. We further hypothesized that P. gingivalis-associated
* Corresponding author. Mailing address: Center for Oral and Sys-
temic Diseases, School of Dentistry, University of North Carolina at
Chapel Hill, Campus Box #7455, Chapel Hill, NC 27599-7455. Phone:
(919) 962-7081. Fax: (919) 966-7537. E-mail: steve_offenbacher
@dentistry.unc.edu.
5163
immune responses would be characterized by a shift of placen-
tal antiinflammatory Th2-type immunity to proinflammatory
Th1-type immunity and, consequently, induce the occurrence
of pregnancy complications, such as FGR and fetal death.
MATERIALS AND METHODS
Animal experiments. A mouse subcutaneous chamber model was used to
establish a localized infection with P. gingivalis strain A7436. Animal husbandry
and bacterial preparation for inoculation are described in detail in Lin et al. (15).
Briefly, mice were implanted with stainless steel chambers and immunized with
109 CFU of heat-killed P. gingivalis. Female mice were bred with the same-strain
male mice and challenged with 107 CFU of live P. gingivalis on gestation day
(GD) 7.5, while the control group received broth. On GD 16.5, animals were
sacrificed and pregnancy outcomes were assessed. FGR was defined as fetuses
with weights 2 standard deviations (SD) smaller (i.e., less than 0.46 g) than
normal fetal weight (NFW; 0.56  0.05 g). Amniotic fluid was collected from
each fetal-placental unit and pooled per pregnant animal. Placentas and fetuses
were collected, washed with sterile saline solution, and stored at 80°C for
future use.
mRNA expression of cytokines in placenta. mRNA expression of cytokines was
analyzed from all placentas from FGR fetuses and their littermates and from
selected placentas (numbers 1, 3, 5, 7, etc.) from the control group and the P.
gingivalis-challenged group with all normal-weight fetuses. Total RNA from each
placenta was extracted using Tri reagent (Sigma, St. Louis, Mo.) according to the
manufacturer’s instructions. Briefly, placental samples were cut into half, and
one half was homogenized and digested in 500 l of Tri reagent for 5 min at
room temperature to ensure complete dissociation of nucleoprotein complexes.
After adding 100 l of chloroform with vigorous shaking, samples were centri-
fuged at 12,000  g for 15 min at 4°C, which separated the mixture into three
phases. The aqueous phase containing RNA was collected and mixed with 250 l
of isopropanol. After centrifugation, the supernatant was removed and the RNA
pellet was washed with 75% ethanol. After drying the pellet for 10 min with air,
10 l of DNase-RNase-free water was added to dissolve the RNA pellet. The
concentration of each RNA sample was adjusted to 1 g/l. cDNA was synthe-
sized using a first-strand cDNA synthesis kit (Amersham Pharmacia Biotech).
Briefly, 1 g of total RNA was reverse transcribed in a total volume of 15 l
using cloned FPL CpureMurine reverse transcriptase, and first-strand cDNA was
synthesized using NotI-d(T)18 bifunctional primer according to standard proce-
dures. Specific primers were used for PCR to obtain double-stranded DNA
(amplicon) of IFN- (8), IL-2 (11), IL-12 (12), IL-4 (23), IL-10 (19), TNF- (10),
TGF-2 (31), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, a
housekeeping gene) for each sample.
Following PCR amplification, amplicons (10 l) were separated by 2% Tris-
acetate (1 TAE) agarose gel electrophoresis and stained with 0.5 g of SYBR
Gold (Molecular Probes, Eugene, Oreg.)/ml. We used LumiAnalyst combined
with Image Analysis software version 3.1 (Boehringer Mannheim GmbH, Mann-
heim, Germany) to measure the relative intensities of bands corresponding to
specific amplicons. Relative levels of mRNA were expressed by calculating the
ratio of each band’s intensity (i.e., specific DNA of each sample) normalized to
the intensity of the GAPDH signal.
P. gingivalis detection. All placentas from FGR fetuses and their littermates
were analyzed for P. gingivalis DNA. Two placentas selected from control dams
and selected placentas (numbers 1, 3, 5, 7, etc.) from P. gingivalis-challenged
dams with all normal-weight fetuses were analyzed. DNA from placental tissue
of NFW and FGR fetuses or whole fetuses was extracted for the detection of P.
gingivalis as described elsewhere (15). Each placenta or fetus was scored as
positive or negative for the presence of P. gingivalis DNA detected by PCR.
Positive controls included P. gingivalis alone or tissues spiked with exogenous P.
gingivalis. The detection limit for P. gingivalis alone was 10 CFU/PCR, and the
detection limit for the P. gingivalis-spiked tissues was 100 CFU/PCR (data not
shown). Six representative amniotic fluid samples from dams with FGR were
cultured (as described previously in reference 15) to determine whether live
bacteria were present.
Statistical analysis. To determine whether fetal exposure to P. gingivalis, as
determined by P. gingivalis DNA in placental samples, was correlated with FGR,
exact logistic regression models were used to control for clustering of fetuses
within dams. Similarly, the effects of P. gingivalis on mean fetal weight were
adjusted for litter-dam clustering using mixed models with the dam as a random
stratification factor, with a P value of less than 0.05 as statistically significant. In
addition, statistically significant differences in placental cytokine mRNA expres-
sion were determined by conditional logistic regression with exact inference for
small sample size to control for clustering of mouse pups within dams by treating
the dam as a factor in a stratified model (16, 27). Relative cytokine expression for
individual cytokines and for Th1 and Th2 groups of cytokines was compared
separately for placentas of fetuses in challenged versus control dams and for
growth-restricted fetuses versus normal-weight fetuses among challenged dams
using mixed models with the dam as a random stratification factor. Results are
presented as mean values  the standard error of the mean for the different
groups of dams. Data were analyzed using Statistical Analysis Software (SAS
Institute, Cary, N.C.).
A Z score transformation was completed to normalize Th1 or Th2 profiles and
to determine relative shifts in the overall Th1/Th2 ratio. Individual cytokine
values for each placenta within each dam were transformed into Z scores (equa-
tion 1). Individual Z scores for each individual cytokine were averaged for the
placentas to arrive at a cytokine-specific Z score for each dam (equation 2). Z
scores for Th1- and Th2-type cytokines were computed for dams by averaging the
Z scores of Th1 (IFN- and IL-2 plus IL-12) (equation 3) and the Z scores of Th2
(IL-4 plus IL-10) (equation 4).
Zcytokine specific for each placenta 	
Xi  Xmean
SD (1)
where Xi is the relative intensity of a specific cytokine mRNA over GAPDH
intensity in an individual placenta, Xmean is the mean relative intensity of a
specific cytokine mRNA in all placental samples, and SD is the standard devia-
tion of the mean of relative intensity of a specific cytokine mRNA in all placental
samples.
Zcytokine specific for each dam 	 Average of Zcytokine specific for each placenta (2)
ZTh1 	 Average of (ZIFN-  ZIL-2  ZIL-12) (3)
ZTh2 	 Average of (ZIL-4  ZIL-10) (4)
RESULTS
Exposure of mice to P. gingivalis during pregnancy resulted
in two possible outcomes for the litters. Either all fetuses were
normal weight (NFW), or one or more fetuses in the litter were
low weight (FGR). Because abortifacient or teratogenic agents
seldom have 100% penetrance, a litter with both normal and
low-weight fetuses provides an opportunity to examine differ-
ences at the placental and fetal levels. These groups help dis-
tinguish effects mediated through maternal mechanisms or pla-
cental and fetal mechanisms. Consequently, placental results
were divided into four groups: group I, placentas from control
dams (36 placentas from 8 dams); group II, placentas from P.
gingivalis-challenged dams with all normal-weight fetuses (32
placentas from 12 dams); group III, placentas of normal-
weight fetuses from P. gingivalis-challenged dams with both
normal- and low-weight fetuses within the litter (18 placentas
from 5 dams); and group IV, placentas of low-weight fetuses
from P. gingivalis-challenged dams with one or more low-
weight fetuses within the litter (30 placentas from 8 dams).
Detection of placental P. gingivalis by PCR. In the broth-
challenged control group (group I), all placental samples ex-
amined (two per mouse) were negative for P. gingivalis DNA
(data not shown). In the 20 P. gingivalis-challenged animals,
eight dams had one or more FGR fetuses. Overall, there was a
total of 107 fetuses scored as P. gingivalis positive or negative
and as FGR present or absent (Table 1). For the 31 placentas
from FGR fetuses, 39% had positive PCR signals for P. gingi-
valis and 61% were P. gingivalis negative (Table 1). All of the
76 NFW fetuses had placentas that were also P. gingivalis
negative.
The mean fetal weight of the FGR P. gingivalis-positive
group was significantly lower than that of the FGR P. gingivalis-
negative and NFW groups (Table 1). In addition, the fetal
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weight of the FGR P. gingivalis-negative group was also signif-
icantly less than that of the NFW fetuses (Table 1). As an
example, Fig. 1 shows the P. gingivalis distribution in placental
tissues of a representative P. gingivalis-challenged dam. PCR
signals from placental tissue taken from littermates (two NFW,
two FGR) are shown. Note that no P. gingivalis amplicon signal
was present for the two NFW fetuses, but signal was present
for both FGR fetuses. The association between P. gingivalis
signal in placenta and FGR was statistically significant at a P
level of 
0.001 (Table 1). In contrast, there was no detectable
P. gingivalis PCR signal in FGR or NFW fetuses, nor was there
live P. gingivalis detected in the anaerobic culture of amniotic
fluid from either FGR or NFW fetuses (data not shown).
Placental mRNA expression of Th1- and Th2-type cytokines.
The relative expressions of selected genes (Th1 cytokines
IFN-, IL-2, and IL-12; Th2 cytokines IL-4 and IL-10; a
proinflammatory cytokine, TNF-; and an immunosuppres-
sive cytokine, TGF-2) in placenta are shown in Table 2.
When cytokine mRNA expression in placentas from control
dams (group I) was compared with that in placentas from all
challenged dams collectively (groups II, III, and IV), IFN-
was increased from 1.8 to 5.7% (P 	 0.0031) and IL-2 was
increased from 0.2 to 3.5% (P 	 0.0007). In contrast, mRNA
expression for IL-4 was decreased from 17.1 to 7.1% (P 	
0.0022) and TGF-2 decreased from 59.8 to 18.5% (P 	
0.0064). These data are consistent with our hypothesis that
live P. gingivalis infection is associated with increases in
inflammatory Th1-type cytokines (IFN- and IL-2) and de-
creases in antiinflammatory Th2-type (IL-4) and immuno-
suppressive (TGF-2) cytokines. To further examine the
relationship between changes in Th1- and Th2-type cyto-
kines after challenge with P. gingivalis, the challenged group
was subdivided into groups II, III, and IV based on fetal
weights (Table 2). When cytokine mRNA expression in pla-
centas of FGR fetuses (group IV) was compared with that in
their littermates (group III), all Th1-type cytokines exam-
ined (IFN-, IL-2, and IL-12) increased significantly (P 

0.05), while IL-10 decreased significantly (P 	 0.05). When
cytokine mRNA expression in placentas of FGR fetuses
(group IV) was compared with that in the control group
(group I), Th1-type cytokines (IFN- and IL-2) were signif-
icantly increased while Th2-type cytokines (IL-4 and IL-10)
were significantly decreased (P 
 0.05).
Changes in the Th1/Th2 ratio after P. gingivalis challenge in
placentas of low-weight fetuses. The average Z scores of Th1-
or Th2-type cytokines were used to demonstrate the relative
balance in the placental Th1 and Th2 immunity after P. gingi-
valis challenge (Fig. 2). In the control group, Th2 was domi-
nant in the placenta (Fig. 2, group I). However, following P.
gingivalis challenge, Th2-type cytokines were lower while Th1-
type cytokines were higher, with a loss in Th2 dominance (Fig.
2, groups II and III). Although normal-weight fetuses in the
challenged group maintained a similar placental Th1/Th2 pro-
file as those in the control group, growth-restricted fetuses
demonstrated an inversion in the cytokine ratio, with a shift to
a predominant Th1 cytokine profile (Fig. 2, group IV).
FIG. 1. PCR detection of P. gingivalis DNA in placentas from NFW
and FGR littermates. P. gingivalis DNA PCR signals were detected in
placentas from two FGR fetuses, but not in placentas from their two
normal-weight littermates (NFW). Representatives of NFW and FGR
fetuses are shown below.
TABLE 1. Average fetal weight and PCR detection of P. gingivalis









wt  SD (g)
FGRa Yes 12 0.27  0.09c
No 19 0.39  0.04d
NFWb Yes 0
No 76 0.55  0.03
a FGR, fetal growth restriction.
b NFW, normal fetal weight.
c Significantly different from FGR P. gingivalis negative and NFW (P 
 0.001;
mixed models with the dam as a random stratification factor).
d Significantly different from NFW (P 
 0.001; mixed models with the dam as
a random stratification factor).
TABLE 2. Relative intensity of cytokine mRNA expression in
placentas of control and P. gingivalis-challenged groupsa
Cytokine
Relative mRNA expression in group
(no. of placentas analyzed)
I (36) II (32) III (18) IV (30)
Th1
IFN- 1.8  1.1 3.7  1.1 3.4  0.9 11.5  1.4b,c
IL-2 0.2  0.8 2.3  0.6 2.8  0.7 5.2  1.0b,c
IL-12 19.1  4.6 14.5  5.3 13.2  3.9 30.9  5.3c
Th2
IL-4 17.1  2.6 8.4  3.1 8.9  1.9 4.7  2.7b
IL-10 18.3  5.9 27.7  5.8 20.5  5.6 7.5  7.0b,c
TNF- 13.9  5.1 10.6  6.8 18.9  4.8 16.5  6.3
TGF-2 59.8  10.8 24.6  9.1 19.3  8.9 14.9  9.2b
a Relative intensity was calculated as the specific cytokine/GAPDH ratio (rep-
resented by percentage) conditioning on dam. Group I, placentas from 8 control
dams; group II, placentas from 12 P. gingivalis-challenged dams with all normal-
weight fetuses; group III, placentas of normal-weight fetuses from 5 P. gingivalis-
challenged dams with both normal- and low-weight fetuses in litter; group IV,
placentas of low-weight fetuses from 8 P. gingivalis-challenged dams with one or
more low-weight fetuses.
b P 
 0.05 compared with group I (statistical test).
c P 
 0.05 compared with group III (statistical test).
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DISCUSSION
These data show that maternal P. gingivalis challenge can
result in P. gingivalis translocation to placental tissue and in-
duction of FGR, while nonaffected littermates show no evi-
dence of P. gingivalis signals in their corresponding placentas.
However, P. gingivalis signal was not detected in 61% of pla-
centas from FGR fetuses. The absence of a PCR signal may be
a false-negative finding due to lack of sensitivity, which may be
overcome in future studies using nested PCR. Alternatively,
the effect on fetal growth may not require placental transloca-
tion, as there are effects on circulatory levels of maternal cy-
tokines following P. gingivalis challenge that may impair fetal
growth, such as an increase in maternal serum TNF- levels
(15).
The placenta is a rich source of a variety of cytokines of both
maternal and fetal origins which have an essential role in
maintaining pregnancy and inducing parturition in humans and
animals. Studies investigating ascending vaginal-cervical infec-
tion and adverse pregnancy outcomes have associated changes
in placental cytokine levels with premature rupture of mem-
branes and preterm labor (3). Complicated pregnancy out-
comes (e.g., FGR, abortion, and preeclampsia) are associated
with increased placental proinflammatory Th1-type cytokines
and/or diminished expression of antiinflammatory Th2-type
cytokines (20, 21, 30). For example, TNF- stimulates the
programmed death of human primary villous trophoblast cells,
and IFN- augments TNF-mediated killing of trophoblasts
(35). In addition, the induction of major histocompatibility
complex class I and II molecules on the surface of trophoblast
cells by IFN- presents fetal antigens to maternal T cells and
strengthens cell-mediated immune responses, leading to fetal
rejection (36). Antiinflammatory cytokines (e.g., IL-4 and IL-
10) produced by the placenta have been suggested to play a
vital role in the survival to term of the fetal allograft by coun-
teracting deleterious inflammatory cytokines (e.g., TNF- and
IFN-), which would ordinarily be expected to protect an in-
dividual from tissue with foreign antigens (5, 9, 18, 29).
P. gingivalis infection in this model appears to induce a
placental shift in Th1 and Th2 cytokine expression (Table 2). P.
gingivalis challenge that resulted in FGR was associated with a
6.4-, 26-, and 1.6-fold increase in placental IFN-, IL-2, and
IL-12, respectively, as well as a 3.6- and 2.5-fold decrease in
IL-4 and IL-10, respectively, compared to the control group.
These findings parallel the observed shifts in Th1 and Th2
associated with vaginal infection.
Previous work with this model (15) demonstrated that P.
gingivalis challenge induces maternal immune responses, as
shown by an elevation in the serum proinflammatory cytokine
TNF- and a decrease in the antiinflammatory cytokine IL-10.
These systemic changes have been associated with FGR. Our
FIG. 2. Average Z scores of mRNA expression of Th1- or Th2-type cytokines in placentas from different treatment and fetal-weight groups.
Group I, placentas from fetuses from control dams; group II, placentas from P. gingivalis-challenged dams with all normal-weight fetuses; groups
III and IV, placentas from NFW fetuses (group III) or FGR fetuses (group IV) from P. gingivalis-challenged dams with at least one FGR fetus
in their litters.
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findings here, suggesting that the translocation of P. gingivalis
into the placenta was associated with the incidence of FGR,
were also consistent with the changes of pro- and antiinflam-
matory cytokine mRNA expression in the placentas. These
observations indicate that the disseminated organism can in-
duce placental inflammation. However, we found no evidence
that P. gingivalis was present in either the fetus or the amniotic
fluid samples obtained from P. gingivalis-challenged dams by
PCR or culture methods (data not shown). Furthermore, when
amniotic fluid was analyzed using enzyme-linked immunoas-
says for the cytokines listed in Table 2, amniotic fluid showed
no detectable changes in cytokine concentrations (data not
shown). Therefore, our data suggest that placental immune
and inflammatory responses are correlated with consequent
abnormal pregnancy outcomes and may result from placental
invasion by P. gingivalis and/or its virulence factors, or from the
maternal inflammatory responses to P. gingivalis challenge.
Our findings are consistent with the concept that P. gingivalis
infection suppresses expression of protective Th2 cytokines as
well as the immunosuppressive cytokine TGF-2. When P.
gingivalis also results in FGR, there is a specific enhancement
of Th1 cytokine profiles not seen in the placentas from normal-
weight fetuses, even in littermates of FGR fetuses. These data
suggest that FGR occurs only when there is a dual effect of Th2
suppression and Th1 enhancement.
In conclusion, in the mouse chamber model, localized P.
gingivalis infection can disseminate to the placenta and is as-
sociated with a shift in placental Th2-type humoral immunity
to Th1-type cellular immunity and also FGR or fetal death
(15). After P. gingivalis challenge, several changes occur in
both maternal and fetal tissues that are correlated with FGR
fetuses. Table 3 summarizes the changes reported from our
previous work (15) as well as the present study. These results
support the hypothesis that proinflammatory Th1 cytokine
dominance during pregnancy is correlated with adverse preg-
nancy outcomes. The data suggest that as long as antiinflam-
matory Th2-type cytokines maintain a balance with proinflam-
matory Th1-type cytokines in the placenta, the fetus is normal
weight even in litters containing FGR littermates.
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